Section Arrow
PHAR.NASDAQ
- Pharming Group NV
Quotes are at least 15-min delayed:2026/05/25 13:36 EDT
Regular Hours
Last
 12.6
-0.21 (-1.64%)
Day High 
13.19 
Prev. Close
12.81 
1-M High
17.12 
Volume 
25.52K 
Bid
13.02
Ask
13.4
Day Low
12.34 
Open
12.97 
1-M Low
11.8301 
Market Cap 
904.71M 
Currency 美元 
P/E 66.32 
%Yield -- 
10-SMA 12.84 
20-SMA 14.46 
50-SMA 15.65 
52-W High 21.34 
52-W Low 9.5354 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
0.19/0.46
Enterprise Value
1.01B
Balance Sheet
Book Value Per Share
3.81
Cash Flow
Cash Flow Yield
0.06
Income Statement
Total Revenue
376.13M
Operating Revenue Per Share
3.10
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
GOVXGeoVax Labs Inc.3.64+0.89+32.36%-- 
MTVAMetaVia Inc.3.85+0.98+34.15%-- 
AKTXAkari Therapeutics Plc18.27+13.13+255.45%-- 
LIMNLiminatus Pharma Inc0.1694-0.0766-31.14%-- 
IOVAIovance Biotherapeutics4.11+0.41+11.08%-- 
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Pharming Group is a biotechnology company focused on developing and commercializing therapies for rare and ultra-rare diseases, particularly immunological and genetic conditions with high unmet need. It operates as an integrated company with capabilities across clinical development, manufacturing, regulatory affairs, and commercialization, supported by scientific and operational expertise. It leverages its efficient infrastructure to expand its pipeline and improve patient access to treatment. The Company operates in the United States, Europe, and the rest of the world, with the United States contributing the majority of its revenue.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.